Regulation of parathyroid function by the amyloid precursor protein
淀粉样前体蛋白对甲状旁腺功能的调节
基本信息
- 批准号:10225816
- 负责人:
- 金额:$ 28.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAffectAgeAgingAmyloidAmyloid Beta A4 Precursor ProteinAmyloid beta-ProteinAmyloid beta-Protein PrecursorAttenuatedBehaviorBindingBinding ProteinsBiochemicalBiological AssayBiological ModelsCalciumCalcium SignalingCalcium-Sensing ReceptorsCell Culture TechniquesCellsChronicCleaved cellClinicalComplexCouplingDataDefectDiseaseDoseElderlyEndocrineEnzyme-Linked Immunosorbent AssayEvaluationFailureFeedbackFosteringFunctional disorderG-Protein-Coupled ReceptorsGABA-B ReceptorGTP-Binding ProteinsGenetic ModelsGlandHealthHeterogeneityHomeostasisHormonalHormone secretionHumanHypercalcemiaHyperparathyroidismHypoparathyroidismImpaired cognitionIn SituIn VitroIncidenceIndividualIntestinesKidneyKnock-outKnockout MiceLigandsLinkLoxP-flanked alleleMass Spectrum AnalysisMediatingMineralsMolecularMusMutationNeuronsNormal tissue morphologyOrganOrgan Culture TechniquesOutcomePTH geneParathyroid AdenomaParathyroid NeoplasmsParathyroid glandPathologicPathway interactionsPatientsPeptide HydrolasesPeptidesPhenotypePhysiologicalPopulationPost-Translational Protein ProcessingProductionPropertyProteinsPublishingRNAReceptor SignalingRegulationReportingRoleSeriesSerumSignal TransductionSubgroupSystemTestingTherapeutic InterventionTimeTissuesUp-RegulationVariantVulnerable PopulationsWorkadenomaage relatedalpha secretaseamyloid peptideamyloid precursor protein processingattenuationbasebehavioral responsebeta secretasebonebone masscalcium absorptioncalcium metabolismcomparativeexperimental studyfracture riskgamma secretasegamma-Aminobutyric Acidin vivoinnovationmicroCTmouse modelneoplasticnovelparacrinereceptorresponsesecretaseskeletaltranscriptomics
项目摘要
Primary hyperparathyroidism (PHPT) is a common endocrine neoplastic disorder that predominantly occurs in the elderly. PHPT affects 15 to 30 individuals per 100,000 in the U.S., an overall incidence that has been steadily rising as the nation’s mean population ages. The disease is biochemically defined by constitutively elevated secretion of parathyroid hormone (PTH) from neoplastic parathyroid tissue, leading to chronic hypercalcemia and a spectrum of clinical sequelae including bone mass attrition and increased fracture risk. While the central physiological deficit in PHPT – the failure to maintain calcium homeostasis – is well recognized, the underlying molecular mechanisms that drive this systemic dysfunction have not been fully characterized. A major limitation to studying calcium sensing in normal and neoplastic parathyroid tissue has been the lack of experimentally tractable model systems that can faithfully reproduce the dynamic calcium response behaviors of the intact organ. To address this, our group has developed a series of ex vivo intact tissue assays that allow interrogative assessment of parathyroid gland function in response to dynamic changes in ambient calcium concentration. Through comparative assessment of normal and neoplastic human parathyroid tissue, we found molecular and biochemical functional heterogeneity among parathyroid adenomas that correlated to phenotypic variations in clinical presentation. In parallel, using a series of murine genetic models our group has recently demonstrated that heterocomplex formation between the calcium sensing receptor (CaSR) and the metabotropic GABAB1 receptor (GABAB1R) can attenuate calcium responsiveness, uncoupling PTH secretion from ambient calcium sensing. The abundance of GABAB1R/CaSR complexes was found to be increased in parathyroid adenomas from patients with PHPT, suggesting that upregulation of GABAB1R/CaSR heterodimer formation could contribute to the attenuation of calcium sensing in neoplastic parathyroid tissue. Indeed, based on recently published work in neuronal systems reporting that various cleaved peptides of the amyloid precursor protein (APP) bind and activate GABAB1R, we have found that tonic secretion of PTH by murine parathyroid tissue is stimulated by co-incubation with b-amyloid (Ab), a peptide cleavage product of APP. We further showed robust expression of APP and all 3 key secretases involved in cleavage of APP-related peptides (sAPPa, sAPPb, and Ab) in human parathyroid adenomas and murine parathyroid glands, implicating a novel paracrine mechanism that may foster functional heterogeneity in parathyroid adenomas. We propose to delineate this mechanism by (1) quantitating the expression of the various APP-derived peptides and determining their impact on calcium signaling and PTH secretion in normal and PHPT adenoma human parathyroid tissue; and (2) investigating the effects of parathyroid-specific APP knockout on mineral, skeletal, and hormonal homeostasis in vivo. The discovery of this entirely novel signaling axis represents a provocative new conceptual pathway potentially linking age-dependent post-translational processing of APP to the increased incidence of PHPT in the elderly.
原发性甲状旁腺功能亢进症 (PHPT) 是一种常见的内分泌肿瘤疾病,在美国每 10 万人中就有 15 至 30 人患有 PHPT,总体发病率随着国家平均人口老龄化而稳步上升。甲状旁腺肿瘤组织分泌的甲状旁腺激素 (PTH) 持续升高,导致慢性高钙血症和包括骨量在内的一系列临床后遗症虽然 PHPT 的主要生理缺陷(无法维持钙稳态)已得到充分认识,但驱动这种系统功能障碍的潜在分子机制尚未得到充分表征,这是研究正常和钙传感的主要限制。肿瘤性甲状旁腺组织一直缺乏能够忠实再现完整器官的动态钙反应行为的实验易处理的模型系统。为了解决这个问题,我们的小组开发了一系列离体完整组织测定,可以对甲状旁腺功能进行质疑评估。在通过对正常和肿瘤性人类甲状旁腺组织的比较评估,我们发现甲状旁腺腺瘤的分子和生化功能异质性与临床表现的表型变异相关。研究小组最近证明,钙敏感受体(CaSR)和代谢型 GABAB1 受体(GABAB1R)之间形成的异质复合物可以减弱钙反应性,从而使 PTH 分泌与周围钙离子解偶联根据最近发表的研究,发现 PHPT 患者的甲状旁腺腺瘤中 GABAB1R/CaSR 复合物的丰度增加,这表明 GABAB1R/CaSR 异二聚体形成的上调可能有助于肿瘤性甲状旁腺组织中钙感应的减弱。在神经系统中工作,报告淀粉样前体蛋白 (APP) 的各种裂解肽结合并激活 GABAB1R,我们发现,小鼠甲状旁腺组织的 PTH 通过与 APP 的肽裂解产物 b-淀粉样蛋白 (Ab) 共孵育而受到刺激。我们进一步显示了 APP 以及参与 APP 相关肽(sAPPa、sAPPb)裂解的所有 3 种关键分泌酶的强劲表达。 ,和 Ab)在人甲状旁腺腺瘤和鼠甲状旁腺中,暗示一种新的旁分泌机制可能促进甲状旁腺的功能异质性我们建议通过(1)定量各种 APP 衍生肽的表达并确定它们对正常和 PHPT 腺瘤人甲状旁腺组织中钙信号和 PTH 分泌的影响;以及(2)研究甲状旁腺的影响来描述这一机制。 -体内矿物质、骨骼和激素稳态的特异性 APP 敲除这一全新信号轴的发现代表了一条可能与年龄依赖性相关的令人兴奋的新概念途径。 APP 翻译后加工导致老年人 PHPT 发病率增加。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wenhan Chang其他文献
Wenhan Chang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wenhan Chang', 18)}}的其他基金
ShEEP Request for NanoString GeoMx Digital Spatial Profiling System
ShEEP 请求 NanoString GeoMx 数字空间剖析系统
- 批准号:
10741001 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
Vitamin D and beta-amyloid signaling in hyperparathyroidism
甲状旁腺功能亢进症中的维生素 D 和 β-淀粉样蛋白信号传导
- 批准号:
10668177 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10365254 - 财政年份:2021
- 资助金额:
$ 28.26万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10531570 - 财政年份:2021
- 资助金额:
$ 28.26万 - 项目类别:
Regulation of parathyroid function by the amyloid precursor protein
淀粉样前体蛋白对甲状旁腺功能的调节
- 批准号:
10398252 - 财政年份:2021
- 资助金额:
$ 28.26万 - 项目类别:
Regulation of Parathyroid Functions By G-Protein Coupled Receptors
G 蛋白偶联受体对甲状旁腺功能的调节
- 批准号:
9809393 - 财政年份:2019
- 资助金额:
$ 28.26万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Single cell transcriptomics of nerves that lack Remak bundles
缺乏 Remak 束的神经的单细胞转录组学
- 批准号:
10649087 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
The role of dendritic cells in heart valve extracellular matrix remodeling, homeostasis, and disease
树突状细胞在心脏瓣膜细胞外基质重塑、稳态和疾病中的作用
- 批准号:
10672638 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
Functional, structural, and computational consequences of NMDA receptor ablation at medial prefrontal cortex synapses
内侧前额皮质突触 NMDA 受体消融的功能、结构和计算后果
- 批准号:
10677047 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
Functional, structural, and computational consequences of NMDA receptor ablation at medial prefrontal cortex synapses
内侧前额皮质突触 NMDA 受体消融的功能、结构和计算后果
- 批准号:
10677047 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
Mitochondrial proton leak and neonatal brain injury
线粒体质子泄漏与新生儿脑损伤
- 批准号:
10724518 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别: